Transactions

TYME Technologies, Inc.’s all-stock merger with Syros Pharmaceuticals and concurrent PIPE

Date Announced:
07/05/2022

client:
TYME Technologies, Inc.

Status:
Pending

Value:
$130 million

Clear all

Download CSV